Skip to content
Caldera Therapeutics
-
Caldera Therapeutics raises USD112.5M to advance novel IBD treatments
Caldera raised USD75 million in a Series A financing round led by Atlas Venture, LAV, and venBio, followed by an additional USD37.5 million in a Series A-1 round led by Omega Funds.